Silas Zindel—13PHOTO/Redux Early in Vas Narasimhan’s career as a physician scientist, he worked on programs for treating HIV/AIDS in Africa and saw the impact of medicine in places that need ...

Novartis’ head of drug development Vas Narasimhan talks about the company’s stake in CAR-T immunotherapy. These cell therapies are set to transform treatment of blood cancers – but questions ...

With the goal to become a top 3 pharma company in China, Novartis has been busy tapping into the expertise of local ...

May 8, 2025 – Today, TIME reveals the second annual TIME100 Health list recognizing the 100 most influential individuals in health.

The comprehensive restructuring of Novartis under new CEO Vas Narasimhan resulted in $15 billion in bolt-on acquisitions last year, and he wants to keep up that momentum. Speaking on Novartis ...

Vas Narasimhan is global head of drug development and chief medical officer at Novartis, and spoke to pharmaphorum at the company’s recent Q4 results conference. He says numerous pilot studies ...

New CEO Vas Narasimhan wants to cut Novartis' R&D costs by using digital tech – and with this in mind the firm has scaled up a project involving virtual clinical trials. The Swiss pharma company ...

Novartis chief executive Vas Narasimhan, already eyeing a possible divestment of generics business Sandoz, has now turned his attention to the rest of the company. The Swiss group will see major ...

Novartis’ new CEO Vas Narasimhan has shown his priorities by promoting the company’s digital chief to the executive committee. New broom and chief digital officer Bertrand Bodson has been ...

Vas Narasimhan. Announcing the selection of Mr Pate and Mrs Bako-Aiyegbusi, the ministry, in a statement signed by its Deputy Director of Press and Public Relations, Alaba Balogun, noted that the ...